Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia	Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system disorder, drug-induced dyskinesia, movement disorder, nervous system disorder, tardive dyskinesia	Recruiting	Phase 2	2026-06-23		NCT07365462

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Neurocrine Biosciences	21

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials